Hikal reports Q1 FY26 consolidated loss of Rs. 22.4 Cr
Hikal has reported total income of Rs. 381.4 crores during the period ended June 30, 2025
Hikal has reported total income of Rs. 381.4 crores during the period ended June 30, 2025
Mehta brings strong leadership experience in biopharmaceuticals, life science research, and diagnostics
NewCo’s pipeline includes five investigational medicines
He has previously served in pivotal HR leadership roles at RPG Life Sciences, Akumentis Healthcare, and Wockhardt
Kushwaha previously served as Chief Digital & Information Officer at Jubilant Ingrevia Limited
Dr. Rao has over 29 years of experience in manufacturing, R&D, business operations, and customer service
Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date
The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026
New platform powered by Opentrons expands lab automation to accelerate scientific discovery
Subscribe To Our Newsletter & Stay Updated